Search   
MSDS 
:
 Ammonium oxalate, 4% aqueous solution w/v
CAS 
:
 1113-38-8
SYNONYMS 
:
 Diammonium oxalate; Ethanedioic acid diammonium salt; Oxalic acid,     diammonium salt.
**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****

+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 1113-38-8 |Ammonium oxalate | 4 | 214-202-3 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | 96 | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

**** SECTION 3 - HAZARDS IDENTIFICATION ****

EMERGENCY OVERVIEW
Not available.

Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Oxalate is an irritant and may cause
dermatitis. Skin lesions begin with epithelial cracking and the
formation of slow-healing ulcers. The fingers may appear cyanotic.
Ingestion:
Systemic effects may be due to formation of calcium oxalate which is
insoluble at physiological pH and can be deposited in the brain and
kidney tubules. Resultant hypocalcemia might disturb the function of
the heart and nerves. Mean lethal dose for oxalates in adults is
estimated at 10 - 30 grams (143 - 428 mg/kg).
Inhalation:
Inhalation of oxalic acid dust or vapor produces irritation of the
respiratory tract, protein in the urine, nosebleed, ulceration of the
mucous membranes, headache, nervousness, cough, vomiting, emaciation,
back pain (due to kidney injury), and weakness.
Chronic:
Inhalation of oxalic acid dust or mist over a long period of time
might result in weight loss and respiratory tract inflammation. Rats
administered oxalic acid at 2.5 and 5% in the diet for 70 days
developed depressed thyroid function and weight loss. A study of
railroad car cleaners in Norway who were heavily exposed to oxalic
acid solutions and vapors revealed a 53% prevalence of urolithiasis
(the formation of urinary stones), compared to a rate of 12% among
unexposed workers from the same company.

**** SECTION 4 - FIRST AID MEASURES ****

Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, immediately flush skin with plenty of water for
at least 15 minutes while removing contaminated clothing and shoes.
Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give
anything by mouth to an unconscious person.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Antidote:
Intravenous administration of calcium gluconate or calcium chloride
may be required if hypocalcemia or hypocalcemic tetany occur.

**** SECTION 5 - FIRE FIGHTING MEASURES ****

General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****

General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.

**** SECTION 7 - HANDLING and STORAGE ****

Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Oxalates
slowly corrode steel.

**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****

Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 1113-38-8:

CAS# 7732-18-5:


Personal Protective Equipment

Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.

**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: practically neutral
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula: Solution
Molecular Weight: 0

**** SECTION 10 - STABILITY AND REACTIVITY ****

Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Excess heat, Oxalates slowly corrode steel..
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, formic acid,
ammonia.
Hazardous Polymerization: Has not been reported.

**** SECTION 11 - TOXICOLOGICAL INFORMATION ****

RTECS#:
CAS# 1113-38-8: RO2750000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
Not available.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
CAS# 1113-38-8
indicated liver changes and biochemical effects.
Carcinogenicity:
Ammonium oxalate -
Not listed by ACGIH, IARC, or NTP.
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

**** SECTION 12 - ECOLOGICAL INFORMATION ****



**** SECTION 13 - DISPOSAL CONSIDERATIONS ****

Dispose of in a manner consistent with federal, state, and local regulations.

**** SECTION 14 - TRANSPORT INFORMATION ****

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

**** SECTION 15 - REGULATORY INFORMATION ****

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1113-38-8: No information available.
CAS# 7732-18-5: No information available.
Canada
CAS# 1113-38-8 is listed on Canada's DSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 1113-38-8 is not listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1113-38-8 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.

**** SECTION 16 - ADDITIONAL INFORMATION ****

Text for R-phrases from Section 2
MSDS Creation Date: 1/18/2002 Revision #2 Date: 10/29/2003

The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Search More   
ALL MSDS PAGES IN THIS GROUP
NAMECAS
Isopropanol, 70.0% 67-63-0
Di-tert-butyl dicarbonate 24424-99-5
DL-Phenylsuccinic Acid, 98% 635-51-8
Nitric Acid, 50% 7697-37-2
Ammonium Thiocyanate, 0.1N 1762-95-4
Potassium Hydroxide, 1.0N 1310-58-3
Potassium Hydroxide, 0.5N Solution in Ethanol 64-17-5
Nitric acid, 1.0N aqueous solution 7697-37-2
Ammonium hydroxide water solution, <3N NH4OH (<5% as ammonia, NH3) 1336-21-6
Lactic Acid, 1.0 N 50-21-5
Citric acid, 1.0M aqueous solution 77-92-9
Ammonium hydroxide water solution, >3N but <5.7N NH4OH (>5% but <10% 1336-21-6
Ammonium oxalate, 4% aqueous solution w/v 1113-38-8
Potassium Hydroxide Solution, 10.0% 1310-58-3
M-Cresol Purple, 0.1% 2303-01-7
Cresol Red Indicator Solution, 0.04% 7732-18-5
Barium chloride, 0.1N aqueous solution 7732-18-5
Chromic Acid, 10.0% 1333-82-0
2-Chloro-4-(3-Chlorophenyl)-Quinazoline 0-01-1
9-[2-(tert-Butyldimethylsilanyloxy)ethyl]-6-chloro-9H-purine. 0-01-1
3-Phenoxypropyl Bromide, 95% 588-63-6
7-[2-(tert-Butyl-Dimethyl-Silanyloxy)-Ethyl]-6-Chloro-7H-Purine 0-01-1
4-Chloro-5-(2,4-Dichlorophenoxy)-2,6-Dimethyl-Pyrimidine 0-01-1
4-Chloro-6-(4-Methoxy Benzyl) Pyrimidine 0-01-1
6-Chloro-9-Ethyl-9H-Purine 5462-86-2
Propiolic acid, 98% 471-25-0
2-Chloro-4-o-Tolyl Pyrimidine 0-01-1
2-Chloro-4-(3-Chlorophenyl) Pyrimidine 0-01-1
Piperazine, anhydrous, 99% 110-85-0
2,2,2-Trifluoroethylhydrazine, 60 wt% aqueous solution 5042-30-8
4-Chloro-2,6-Dimethyl Pyrimidine 0-01-1
2-Chloro-4-(2-Methyl-2H-Pyrazol-3-yl)-Quinazoline 0-01-1
2-Chloro-4-Pyridin-2-yl-Quinazoline 0-01-1
4-Chloro-7H-Pyrrolo [2,3-d] Pyrimidine 3680-69-1
2-Chloro-4-(1-Methyl-1H-Imidazol-2-yl)-Quinazoline 0-01-1
4,5-Dichloro-6-Ethyl Pyrimidine 0-01-1
4-Chloro-6-(4-Methoxyphenyl)-2-Methyl Pyrimidine 142220-68-6
QUANTI-CULT, Dehydrated Live Organisms 0-00-0
Lancerclean Acid 64-19-7
Carbonate Buffer 497-19-8
Disodium p-Nitrophenyl Phosphate 0-01-1
Cryoscope Bath Liquid 107-21-1
Iron Alum Indicator 7697-37-2
Kovacs Reagent 71-41-0
(1R)-endo-(+)-Fenchol, 96% 2217-02-9
Cryoscope Standards 0-01-1
Diamond Slurry, Water, MD, 30UM 0-01-1
Acetic acid/chloroform, 2:1 mix 64-19-7
Acetic acid, 3% 64-19-7
Congo Red Indicator, 0.1% aqueous 573-58-0

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net